Huiyu Pharmaceuticals: Multiple countries have approved five drugs from the company for listing.

Huiyu Pharmaceuticals announced that the company and its subsidiaries have recently obtained drug approval for listing in Denmark, Germany, Uzbekistan, and Bangladesh, including paclitaxel for injection, cyclophosphamide for injection, paclitaxel injection, zoledronic acid concentrate for injection, and azacitidine for injection. These drugs have been submitted for registration in multiple countries and have been granted market approval, which will help the company expand its product line and enhance its brand image in the international market. The company has made preparations for the pre-launch sales of these products, but the future performance is uncertain due to factors such as market competition.